The costs of schizophrenia

Research output: Contribution to journalReview article

72 Citations (Scopus)

Abstract

Reasonably accurate approximations of the financial costs of schizophrenia are the foundation for making judgments about the socioeconomic impact of the disorder and the cost-effectiveness of treatment modalities. The financial costs of schizophrenia to society can be divided into direct and indirect costs. Direct costs include treatment provided in inpatient, outpatient, and long-term care, as well as criminal justice costs, medication costs, and publicly owned capital such as state mental health facilities. Indirect costs mostly arise from the productivity loss suffered by individuals with schizophrenia, family members, and caregivers. The cost of schizophrenia in the United States in 2002 was estimated to be $62.7 billion. Compared with a 1991 estimate, inpatient costs have declined, whereas outpatient costs and medication costs have increased. When interpreting any data regarding costs, people should be aware of factors that influence results, such as the perspective from which the analysis was undertaken, the measures used in the analysis, and planned or unplanned bias.

Original languageEnglish (US)
Pages (from-to)4-7
Number of pages4
JournalJournal of Clinical Psychiatry
Volume68
Issue numberSUPPL. 14
StatePublished - Dec 1 2007
Externally publishedYes

Fingerprint

Schizophrenia
Costs and Cost Analysis
Inpatients
Outpatients
Criminal Law
Health Facilities
Long-Term Care
Health Care Costs
Caregivers
Cost-Benefit Analysis
Mental Health
Economics

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

The costs of schizophrenia. / McEvoy, Joseph Patrick.

In: Journal of Clinical Psychiatry, Vol. 68, No. SUPPL. 14, 01.12.2007, p. 4-7.

Research output: Contribution to journalReview article

McEvoy, JP 2007, 'The costs of schizophrenia', Journal of Clinical Psychiatry, vol. 68, no. SUPPL. 14, pp. 4-7.
@article{7b33559f361647d0a43cfd0dfb59ae6c,
title = "The costs of schizophrenia",
abstract = "Reasonably accurate approximations of the financial costs of schizophrenia are the foundation for making judgments about the socioeconomic impact of the disorder and the cost-effectiveness of treatment modalities. The financial costs of schizophrenia to society can be divided into direct and indirect costs. Direct costs include treatment provided in inpatient, outpatient, and long-term care, as well as criminal justice costs, medication costs, and publicly owned capital such as state mental health facilities. Indirect costs mostly arise from the productivity loss suffered by individuals with schizophrenia, family members, and caregivers. The cost of schizophrenia in the United States in 2002 was estimated to be $62.7 billion. Compared with a 1991 estimate, inpatient costs have declined, whereas outpatient costs and medication costs have increased. When interpreting any data regarding costs, people should be aware of factors that influence results, such as the perspective from which the analysis was undertaken, the measures used in the analysis, and planned or unplanned bias.",
author = "McEvoy, {Joseph Patrick}",
year = "2007",
month = "12",
day = "1",
language = "English (US)",
volume = "68",
pages = "4--7",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "SUPPL. 14",

}

TY - JOUR

T1 - The costs of schizophrenia

AU - McEvoy, Joseph Patrick

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Reasonably accurate approximations of the financial costs of schizophrenia are the foundation for making judgments about the socioeconomic impact of the disorder and the cost-effectiveness of treatment modalities. The financial costs of schizophrenia to society can be divided into direct and indirect costs. Direct costs include treatment provided in inpatient, outpatient, and long-term care, as well as criminal justice costs, medication costs, and publicly owned capital such as state mental health facilities. Indirect costs mostly arise from the productivity loss suffered by individuals with schizophrenia, family members, and caregivers. The cost of schizophrenia in the United States in 2002 was estimated to be $62.7 billion. Compared with a 1991 estimate, inpatient costs have declined, whereas outpatient costs and medication costs have increased. When interpreting any data regarding costs, people should be aware of factors that influence results, such as the perspective from which the analysis was undertaken, the measures used in the analysis, and planned or unplanned bias.

AB - Reasonably accurate approximations of the financial costs of schizophrenia are the foundation for making judgments about the socioeconomic impact of the disorder and the cost-effectiveness of treatment modalities. The financial costs of schizophrenia to society can be divided into direct and indirect costs. Direct costs include treatment provided in inpatient, outpatient, and long-term care, as well as criminal justice costs, medication costs, and publicly owned capital such as state mental health facilities. Indirect costs mostly arise from the productivity loss suffered by individuals with schizophrenia, family members, and caregivers. The cost of schizophrenia in the United States in 2002 was estimated to be $62.7 billion. Compared with a 1991 estimate, inpatient costs have declined, whereas outpatient costs and medication costs have increased. When interpreting any data regarding costs, people should be aware of factors that influence results, such as the perspective from which the analysis was undertaken, the measures used in the analysis, and planned or unplanned bias.

UR - http://www.scopus.com/inward/record.url?scp=38349175353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38349175353&partnerID=8YFLogxK

M3 - Review article

C2 - 18284271

AN - SCOPUS:38349175353

VL - 68

SP - 4

EP - 7

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - SUPPL. 14

ER -